
PRCT Stock Plunges 15% After Revenue Miss Triggers Securities Fraud Investigation
PROCEPT BioRobotics faces securities fraud investigation after missing earnings and cutting 2026 guidance by $20-30 million, triggering a 15% stock plunge.
PRCTshareholder lawsuitstock price decline